XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Cumulative effect, period of adoption, adjustment
Cumulative effect, period of adoption, adjustment
Accumulated Deficit
Beginning balance (in shares) at Mar. 31, 2020   103,179          
Beginning balance at Mar. 31, 2020 $ 190,731 $ 103 $ 625,474 $ (12,176) $ (422,670) $ (2,800) $ (2,800)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under stock plans (in shares)   688          
Issuance of common stock under stock plans (66) $ 1 (67)        
Stock-based compensation expense 23,118   23,118        
Issuance of common stock related to acquisition 8,489   8,489        
Unrealized investment (loss) gain 422     422      
Foreign currency translation adjustment 885     885      
Net loss (41,913)       (41,913)    
Ending balance (in shares) at Jun. 30, 2020   103,867          
Ending balance at Jun. 30, 2020 178,866 $ 104 657,014 (10,869) (467,383)    
Beginning balance (in shares) at Mar. 31, 2020   103,179          
Beginning balance at Mar. 31, 2020 190,731 $ 103 625,474 (12,176) (422,670) $ (2,800) $ (2,800)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized investment (loss) gain 306            
Foreign currency translation adjustment 8,367            
Net loss (120,551)            
Ending balance (in shares) at Dec. 31, 2020   107,136          
Ending balance at Dec. 31, 2020 167,403 $ 107 716,820 (3,503) (546,021)    
Beginning balance (in shares) at Jun. 30, 2020   103,867          
Beginning balance at Jun. 30, 2020 178,866 $ 104 657,014 (10,869) (467,383)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under stock plans (in shares)   2,119          
Issuance of common stock under stock plans 4,708 $ 2 4,706        
Stock-based compensation expense 26,396   26,396        
Unrealized investment (loss) gain (43)     (43)      
Foreign currency translation adjustment 2,945     2,945      
Net loss (38,413)       (38,413)    
Ending balance (in shares) at Sep. 30, 2020   105,986          
Ending balance at Sep. 30, 2020 174,459 $ 106 688,116 (7,967) (505,796)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under stock plans (in shares)   1,150          
Issuance of common stock under stock plans 1,347 $ 1 1,346        
Stock-based compensation expense 27,358   27,358        
Unrealized investment (loss) gain (73)     (73)      
Foreign currency translation adjustment 4,537     4,537      
Net loss (40,225)       (40,225)    
Ending balance (in shares) at Dec. 31, 2020   107,136          
Ending balance at Dec. 31, 2020 167,403 $ 107 716,820 (3,503) (546,021)    
Beginning balance (in shares) at Mar. 31, 2021   109,135          
Beginning balance at Mar. 31, 2021 160,504 $ 109 755,643 (4,193) (591,055)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under stock plans (in shares)   1,562          
Issuance of common stock under stock plans 3,440 $ 2 3,438        
Stock-based compensation expense 36,508   36,508        
Unrealized investment (loss) gain (33)     (33)      
Foreign currency translation adjustment 283     283      
Net loss (43,906)       (43,906)    
Ending balance (in shares) at Jun. 30, 2021   110,697          
Ending balance at Jun. 30, 2021 156,796 $ 111 795,589 (3,943) (634,961)    
Beginning balance (in shares) at Mar. 31, 2021   109,135          
Beginning balance at Mar. 31, 2021 160,504 $ 109 755,643 (4,193) (591,055)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Unrealized investment (loss) gain (111)            
Foreign currency translation adjustment (971)            
Net loss (129,801)            
Ending balance (in shares) at Dec. 31, 2021   112,353          
Ending balance at Dec. 31, 2021 117,173 $ 112 843,192 (5,275) (720,856)    
Beginning balance (in shares) at Jun. 30, 2021   110,697          
Beginning balance at Jun. 30, 2021 156,796 $ 111 795,589 (3,943) (634,961)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under stock plans (in shares)   2,721          
Issuance of common stock under stock plans 6,760 $ 2 6,758        
Stock-based compensation expense 33,483   33,483        
Issuance of common stock related to acquisitions (in shares)   (1)          
Issuance of common stock related to acquisition 0            
Unrealized investment (loss) gain (15)            
Foreign currency translation adjustment (2,149)            
Net loss (42,324)       (42,324)    
Ending balance (in shares) at Sep. 30, 2021   113,416          
Ending balance at Sep. 30, 2021 152,551 $ 113 835,830 (6,107) (677,285)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under stock plans (in shares)   1,279          
Issuance of common stock under stock plans 127 $ 1 126        
Stock-based compensation expense 36,611   36,611        
Issuance of common stock related to acquisitions (in shares)   (2)          
Issuance of common stock related to acquisition 0            
Stock Repurchased (in shares)   (2,340)          
Share Repurchase (29,377) $ (2) (29,375)        
Unrealized investment (loss) gain (63)     (63)      
Foreign currency translation adjustment 895     895      
Net loss (43,571)       (43,571)    
Ending balance (in shares) at Dec. 31, 2021   112,353          
Ending balance at Dec. 31, 2021 $ 117,173 $ 112 $ 843,192 $ (5,275) $ (720,856)